The fully linked HTML version of this article has now been published.
JCS ePress
online publication date 16 Jun 2005
doi: 10.1242/jcs.02404
Research Article
Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy
Thai H. Ho,
Rajesh S. Savkur,
Michael G. Poulos,
Michael A. Mancini,
Maurice S. Swanson,
and
Thomas A. Cooper*
* Author for correspondence (e-mail: tcooper{at}bcm.tmc.edu)
Myotonic dystrophy type I (DM1), which is caused by a non-coding CTG-repeat expansion in the dystrophia myotonica-protein kinase (DMPK) gene, is an RNA-mediated disease. Expanded CUG repeats in transcripts of mutant DMPK form nuclear foci that recruit muscleblind-like (MBNL) proteins, a family of alternative splicing factors. Although transcripts of mutant DMPK and MBNL proteins accumulate in nuclear RNA foci, it is not clear whether foci formation is required for splicing mis-regulation. Here, we use a co-transfection strategy to show that both CUG and CAG repeats form RNA foci that colocalize with green fluorescent protein (GFP)-MBNL1 and endogenous MBNL1. However, only CUG repeats alter splicing of the two tested pre-mRNAs, cardiac troponin T (cTNT) and insulin receptor (IR). Using FRAP, we demonstrate that GFP-MBNL1 in CUG and CAG foci have similar half-times of recovery and fractions of immobile molecules, suggesting that GFP-MBNL1 is bound by both CUG and CAG repeats. We also find an immobile fraction of GFP-MBNL1 in DM1 fibroblasts and a similar rapid exchange in endogenous CUG RNA foci. Therefore, formation of RNA foci and disruption of MBNL1-regulated splicing are separable events.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. B. Warf, M. Nakamori, C. M. Matthys, C. A. Thornton, and J. A. Berglund
From the Cover: Pentamidine reverses the splicing defects associated with myotonic dystrophy
PNAS,
November 3, 2009;
106(44):
18551 - 18556.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Yu, A. M. Wang, D. M. Robins, and A. P. Lieberman
Altered RNA splicing contributes to skeletal muscle pathology in Kennedy disease knock-in mice
Dis. Model. Mech.,
September 1, 2009;
2(9-10):
500 - 507.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Holt, V. Jacquemin, M. Fardaei, C. A. Sewry, G. S. Butler-Browne, D. Furling, J. D. Brook, and G. E. Morris
Muscleblind-Like Proteins: Similarities and Differences in Normal and Myotonic Dystrophy Muscle
Am. J. Pathol.,
January 1, 2009;
174(1):
216 - 227.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Zhang, J. E. Lee, J. Wilusz, and C. J. Wilusz
The RNA-binding Protein CUGBP1 Regulates Stability of Tumor Necrosis Factor mRNA in Muscle Cells: IMPLICATIONS FOR MYOTONIC DYSTROPHY
J. Biol. Chem.,
August 15, 2008;
283(33):
22457 - 22463.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. B. Warf and J. A. Berglund
MBNL binds similar RNA structures in the CUG repeats of myotonic dystrophy and its pre-mRNA substrate cardiac troponin T
RNA,
December 1, 2007;
13(12):
2238 - 2251.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Yuan, S. A. Compton, K. Sobczak, M. G. Stenberg, C. A. Thornton, J. D. Griffith, and M. S. Swanson
Muscleblind-like 1 interacts with RNA hairpins in splicing target and pathogenic RNAs
Nucleic Acids Res.,
August 15, 2007;
(2007)
gkm601v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Royo, E. Basyuk, V. Marty, M. Marques, E. Bertrand, and J. Cavaille
Bsr, a Nuclear-retained RNA with Monoallelic Expression
Mol. Biol. Cell,
August 1, 2007;
18(8):
2817 - 2827.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Osborne and C. A. Thornton
RNA-dominant diseases
Hum. Mol. Genet.,
October 15, 2006;
15(suppl_2):
R162 - R169.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. N. Kanadia, J. Shin, Y. Yuan, S. G. Beattie, T. M. Wheeler, C. A. Thornton, and M. S. Swanson
Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy
PNAS,
August 1, 2006;
103(31):
11748 - 11753.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. de Haro, I. Al-Ramahi, B. De Gouyon, L. Ukani, A. Rosa, N. A. Faustino, T. Ashizawa, T. A. Cooper, and J. Botas
MBNL1 and CUGBP1 modify expanded CUG-induced toxicity in a Drosophila model of myotonic dystrophy type 1
Hum. Mol. Genet.,
July 1, 2006;
15(13):
2138 - 2145.
[Abstract]
[Full Text]
[PDF]
|
 |
|
© The Company of Biologists Ltd 2005